LSE - Delayed Quote GBp

Assura Plc (AGR.L)

48.72
-0.06
(-0.12%)
At close: 4:35:08 PM GMT+1
Loading Chart for AGR.L
  • Previous Close 48.78
  • Open 48.78
  • Bid 48.72 x --
  • Ask 48.76 x --
  • Day's Range 48.68 - 48.98
  • 52 Week Range 0.36 - 49.20
  • Volume 3,433,621
  • Avg. Volume 29,640,276
  • Market Cap (intraday) 1.585B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 24.36
  • EPS (TTM) 0.02
  • Earnings Date May 19, 2025 - May 23, 2025
  • Forward Dividend & Yield 0.03 (6.89%)
  • Ex-Dividend Date Mar 6, 2025
  • 1y Target Est 49.67

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders. At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

www.assuraplc.com

84

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AGR.L

View More

Performance Overview: AGR.L

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

AGR.L
27.10%
FTSE 100 (^FTSE)
4.67%

1-Year Return

AGR.L
14.14%
FTSE 100 (^FTSE)
2.07%

3-Year Return

AGR.L
23.18%
FTSE 100 (^FTSE)
18.54%

5-Year Return

AGR.L
37.60%
FTSE 100 (^FTSE)
44.12%

Compare To: AGR.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AGR.L

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    1.59B

  • Enterprise Value

    3.16B

  • Trailing P/E

    23.23

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.97

  • Price/Book (mrq)

    0.99

  • Enterprise Value/Revenue

    19.22

  • Enterprise Value/EBITDA

    32.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    40.21%

  • Return on Assets (ttm)

    2.74%

  • Return on Equity (ttm)

    4.23%

  • Revenue (ttm)

    164.4M

  • Net Income Avi to Common (ttm)

    66.1M

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.2M

  • Total Debt/Equity (mrq)

    100.10%

  • Levered Free Cash Flow (ttm)

    15.39M

Research Analysis: AGR.L

View More

Company Insights: AGR.L

Research Reports: AGR.L

View More

People Also Watch